Skip to content

PTHS PTHS Contingent liabilities

Contingent liabilities at other companies

Blink Charging Co. logo
Blink Charging Co.BLNK
$1.01M
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$5M
Castle Biosciences logo
Castle BiosciencesCSTL
$1M
Alarm.com Holdings logo
Alarm.com HoldingsALRM
$305.75K-43.6%
PTH
Pelthos Therapeutics Inc.PTHS
$1M
Central Garden & Pet Company logo
Central Garden & Pet CompanyCENT
$500K+10,100%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+75.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:AssetAcquisitionContingentConsiderationLiabilityCurrent.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's contingent liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's contingent liabilities?
PTHS (PTHS) reported contingent liabilities of $1M in Q1 2026.
What does contingent liabilities mean?
This represents the estimated fair value of future payments owed to sellers following an acquisition, contingent upon the achievement of specific clinical, regulatory, or commercial milestones. For a clinical-stage biotechnology company, these liabilities often reflect potential payouts tied to successful drug development phases or market approval. Monitoring this balance provides insight into the company's future financial obligations and the risk profile associated with its acquired pipeline assets.